EBJC > CME Statement


EBRU

Evidence-based Reviews in Urology
October 2012 to May 2013

CME


What is Evidence Based Reviews in Urology (EBRU)?
Evidence Based Reviews in Urology (EBRU) is a program by the American Urological Association Education and Research, Inc (AUAER) that will be re-launched into its fourth year in October of 2012 to teach practicing urologists and residents-in-training critical appraisal skills.

[return to top]

What is the format of EBRU?
Evidence based medicine related knowledge and skills will be taught in an online journal club format that will feature eight published articles per academic year (October – May). Participants will be asked to critically appraise the latest clinical research studies in a structured format. Each session will begin with a clinical scenario that raises a specific clinical question, for example whether a patient with locally advanced prostate cancer should receive adjuvant radiation following radical prostatectomy. This provides the back-drop for a critical review of a recent clinical research study which provides some of the current best evidence on that topic. This study is then reviewed and discussed addressing three key questions: 1) are the results likely to be valid, 2) what are the study results, and 3) should the study findings be applied to the care of the specific patient described in the clinical scenario. To facilitate this exercise, evidence based medicine review articles such as those from the Users' Guide to the Urological Literature series published in the Journal of Urology will be provided as a guide.

[return to top]

What kind of articles will be discussed?
Articles will be selected primarily for their suitability in highlighting important methodological issues. Important topic areas that are critical to the understanding of the urological literature include therapy, prognosis, diagnosis, harm, etiology/risk, costs and resource utilization. At the same time, the selected studies will also be highly relevant to the day-to-day clinical practice of urology and provide some of the current best evidence on a given topic. Studies chosen for the 2012-13 academic year will include among others Radical Prostatectomy versus Observation for Localized Prostate Cancer, Dutasteride in Localised Prostate Cancer Management: the REDEEM Randomized, Double-blind, Placebo-controlled Trial and A Randomized Trial of Urodynamic Testing Before Stress-Incontinence Surgery. Following each online group discussion, structured reviews by recognized clinical and methodological experts will also be posted.

[return to top]

Who oversees the EBRU program?
EBRU is a program developed by the AUAER Office of Education. The program is managed by the EBRU Steering Committee composed of recognized leaders in urology with particular expertise in evidence based medicine and clinical research methodology. These individuals will also moderate the online group discussions. The program is modeled after a highly successful educational program by the American College of Surgeons and the Canadian Association of General Surgeons. This framework has been demonstrated to be an effective method of teaching EBM to busy general surgeons in a randomized controlled trial.

[return to top]

What is the educational value of EBRU?
A unique evidence-based medicine training tool, EBRU helps urologists to expand their critical appraisal skills and expand their knowledge of key studies in urologic medicine. EBRU is an easy and interactive way for busy urologists to review the current literature, evaluate new techniques and optimize patient care. Additionally, EBRU provides a forum for urologists to exchange ideas with leading experts and colleagues around the globe. For urology residency programs, EBRU can be used for teaching and assessing resident competency in practice-based learning (PBL) and improvement, as mandated by the ACGME.

[return to top]

Who can participate in EBRU?
EBRU is free to members, residents and non-members of the AUAER. It provides a convenient, practical and interactive way for busy urologists to enhance their critical appraisal skills and increase their clinical knowledge. It is also an excellent learning resource for urology residents and fellows who want to refine their critical appraisal skills.

[return to top]

What is available on the EBRU site?

[return to top]

Learning Objectives:
After completion of the EBRU program, participants should be able to:

[return to top]

Accreditation
The American Urological Association Education and Research, Inc (AUAER) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

[return to top]

Credit Designation
The American Urological Association Education and Research, Inc (AUAER) designates this journal-based CME for a maximum of 16.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AUAER takes responsibility for the content, quality, and scientific integrity of this CME activity.

[return to top]

Target Audience
practicing urologists, residents-in-training, associated health care providers

[return to top]

Method of Participation
There are 8 sessions (October – May). For AMA PRA Category 1 Credits™, participants must

Participants will be notified via email when the materials are available.

Estimated time to complete individual lesson: 2.0 Hours

[return to top]

Release Date: October 1, 2012

Expiration Date: May 31, 2013

Minimum Hardware/Software Requirements

[return to top]

AUA Disclosure Policy
As a provider accredited by the ACCME, the AUAER must insure balance, independence, objectivity and scientific rigor in all its activities.

All faculty participating in an educational activity provided by the AUAER are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUAER must determine if the faculty's relationships may influence the educational content with regard to exposition or conclusion and resolve any conflicts of interest prior to the commencement of the educational activity.

[return to top]

American Urological Association Education and Research, Inc (AUAER) EBRU Committee Disclosures

Philipp Dahm, MD
Professor of Urology
Residency Program Director
Department of Urology
College of Medicine
University of Florida
Gainesville, FL
Disclosures: Nothing to disclose

Luis Braga, MD
Assistant Professor
Department of Surgery
Pediatric Urology
McMaster Children's Hospital
McMaster University
Hamilton, ON
Disclosures: Nothing to disclose

Rodney H. Breau, MD
Associate Scientist, Ottawa Hospital Research Institute
Surgical Oncology, Division of Urology
The Ottawa Hospital/University of Ottawa
Ottawa, ON
Disclosures: Nothing to disclose

Steven E. Canfield, MD
Program Director
Urology Residency
University of Texas Health Science Center- Houston
Chief of Urology
LBJ General Hospital
Houston, TX
Disclosures: Amgen: Meeting Participant or Lecturer

M. Louis Moy, MD
Director for Female Urology and
Reconstructive Surgery
Department of Urology
College of Medicine
University of Florida
Gainesville, FL
Disclosures: Nothing to disclose

J. Kellogg Parsons, MD
Assistant Professor of Surgery
Division of Urologic Oncology
UCSD Moores Cancer Center
LaJolla, CA
Disclosures: AMS: Meeting Participant/Lecturer

David F. Penson, MD
Professor of Urologic Surgery
Director, Center for Surgical Quality and Outcomes Research
Vanderbilt University
Nashville, TN
Disclosures: Nothing to disclose

Charles D. Scales, Jr., MD
Clinical Scholar
Robert Wood Johnson Foundation Clinical Scholars®
University of California
Los Angeles Division of General Internal Medicine
and Health Services Research
Los Angeles, CA
Disclosures: Accreditation Council for Graduate Medical Education

[return to top]

Evidence Based Content
As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUAER to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

[return to top]

Off-label or Unapproved Use of Drugs or Devices
It is the policy of the AUAER to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

[return to top]

Disclaimer
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUAER.

[return to top]

Copyright
©American Urological Association Education and Research, Inc., 2012

AUA Privacy and Confidentiality Policy
www.auanet.org/cme/onlineeduconf.cfm

Contact Information
For all inquiries regarding CME credit please contact:
Enduring Materials Coordinator
American Urological Association
1000 Corporate Boulevard
Linthicum, MD 21090
410-689-3751
CME@AUAnet.org

[return to top]

ADVERTISEMENT

ADVERTISEMENT
Donate
Contact
Press/Media
Sections
Term of Use
Site Map


ADVERTISEMENT